Le Lézard
Classified in: Health, Business
Subject: JVN

Matterhorn, One of the Nation's Most Experienced Healthcare Advisory Firms, Facilitates the Review and Evaluation of Potential Partners for a Home Health Joint Venture.


SAN FRANCISCO, April 24, 2024  /PRNewswire/ -- Matterhorn Strategic Advisors (Matterhorn), a California-based investment bank already known for its strategic expertise in the healthcare sector, has successfully advised John Muir Health in evaluating potential partners for a home health joint venture. That detailed, comprehensive evaluation led to John Muir Health's selection of The Pennant Group as its joint venture partner.

"Matterhorn guided us through the process of identifying and evaluating potential joint venture partners. Throughout that effort, they were extremely responsive and provided us extensive, useful insight regarding potential partners," said George Sauter, former Chief Strategy Officer of John Muir Health. "Matterhorn helped us find, evaluate, and select a strong partner. They're a boutique firm with a highly qualified team of outstanding professionals who delivered what they promised."

Led by the founders, Tom Blankenship and Nate Kaufman, Matterhorn helped develop a comprehensive framework specifically for John Muir Health before facilitating the evaluation of a broad spectrum of potential partners.

John Muir Health is a not-for-profit integrated healthcare system serving Contra Costa County and the greater San Francisco Bay Area. Celebrated for its exceptional quality in primary and specialty care and ancillary services, John Muir Health has more than 1,000 primary care and specialist physicians with more than 6,000 employees across the system.

Headquartered in Eagle, Idaho, The Pennant Group boasts a vast network of 104 home health, hospice, and home care agencies, alongside 53 senior living communities spanning 14 states, united in a commitment to providing life-changing service.

With John Muir Health's robust reputation and Pennant's industry-leading strength in operating home health and hospice agencies, this joint venture holds great promise to expand accessible, quality home health care. The joint venture also underscores Pennant's continued commitment to fostering local leadership and empowering its workforce?a philosophy that resonated with John Muir Health and was pivotal in the selection process.

Reflecting on the collaboration, Tom Blankenship noted, "Pennant's culture and emphasis on local empowerment were key differentiators. While our dedication to guiding John Muir Health through the partner selection process should underscore our prowess in the home health sector."

Matterhorn is poised to leverage this success to attract new clients seeking strategic guidance in home care mergers, acquisitions, or divestitures. "Because, as a boutique firm, what we offer is a level of principal engagement and consistency unmatched by larger firms," Nate Kaufman said.

About Matterhorn Strategic Advisors

Founded in 2021 by Tom Blankenship and Nathan Kaufman, Matterhorn Strategic Advisors is a leading independent investment bank specializing in strategic advisory and solutions for healthcare corporations, not-for-profits, and financial sponsors. With a focus on mergers and acquisitions, capital markets transactions, and corporate finance matters, Matterhorn's team of experienced professionals is dedicated to guiding clients through their most critical decisions.

For more information on Matterhorn's comprehensive suite of advisory services, visit www.MatterhornStrategicAdvisors.com or connect with them on LinkedIn.

Media Contact:

Tom Blankenship
(310) 482-0486
[email protected]

SOURCE Matterhorn Strategic Advisors


These press releases may also interest you

at 06:05
GlycoMimetics, Inc. , a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced topline results from its Phase 3 global pivotal study of uproleselan in...

at 06:05
Northwest Natural Holding Company, (NW Natural Holdings), reported financial results and highlights including: Reported net income of $63.8 million ($1.69 per share) for the first quarter of 2024, compared to net income of $71.7 million ($2.01...

at 06:00
Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterinary Health Division. This enhancement is led by John Boshart, a distinguished figure in animal health with profound experience...

at 06:00
Net income up 14% to $338 million versus $297 million in the prior year quarter; core income up 9% to $355 million, reflecting the best first quarter core income on record, versus $325 million in the prior year quarter.P&C core income of $372 million...

at 06:00
In the news release, PINTEC ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE FIRST HALF OF 2023, issued 28-Dec-2023 by Pintec Technology Holdings Limited over PR Newswire, we are advised by the company that in the Interim Report, the Company disclosed...

at 06:00
KBR announced today it has been awarded a multiple award, Indefinite Delivery Indefinite Quantity (IDIQ) contract by the U.S. Naval Facilities Engineering Systems Command for global contingency services.  ...



News published on and distributed by: